Acetazolamide efficacy in treatment of rolandic epilepsy (SeLECTS) in children

Comparison of acetazolamide and carbamazepine efficacy in treatment of rolandic epilepsy (SeLECTS) in children 7 to 14 years old

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250203064624N1

Enrollment

Registered

2025-04-25

Start date

2025-04-30

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rolandic epilepsy ( SeLECTS ). Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

Interventions

Intervention 1: Intervention group: acetazolamide prescription /In this group, acetazolamide is prescribed in an acceptable dosage in children of 5-10 mg per kilogram of body weight in divided doses p

Eligibility

Sex/Gender

All

Age

7 Years to 14 Years

Inclusion criteria

Inclusion criteria: Children 7-14 years old Children with rolandic epilepsy Confirmation of rolandic epilepsy in patients by pediatric neurologist

Exclusion criteria

Exclusion criteria: If the family or patient is not cooperative for the study If there is no chance to follow the patient

Design outcomes

Primary

Measure	Time frame
The rate of seizures. Timepoint: Examining the amount of convulsions every month for one year. Method of measurement: Asking the patients parents and their caregivers.;The side effects of the drugs. Timepoint: Every month for one year. Method of measurement: Asking the patients parents and their caregivers.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehran Beiraghi Toosi

Mashhad University of Medical Sciences

BeiraghiTM@mums.ac.ir+98 915 508 0287

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026